Alzheimer's Gene Challenges Racial Bias

Brain gene expression study highlights Alzheimer’s disease pathways in African American donors

January 15, 2026
3 min

The Pathologist

Overview

A large study has identified hundreds of genes associated with Alzheimer's disease in African American brain tissue, highlighting significant gene expression differences. This research addresses a critical gap in understanding the disease across diverse populations.

Background

Alzheimer's disease (AD) is a complex neurodegenerative disorder that disproportionately affects various racial groups. Understanding genetic and biological factors in diverse populations is essential for developing targeted therapies and improving diagnosis. This study represents a significant step in addressing racial disparities in Alzheimer's research.

Data Highlights

Gene	Expression in AD Cases	Expression in Controls
ADAMTS2	1.5-fold higher	Baseline
482 genes	Significant differences	Baseline

Key Findings

Identified 482 genes with significant expression differences between AD cases and controls.
ADAMTS2 showed approximately 1.5-fold higher expression in AD cases.
Lower expression of mitochondrial respiratory chain genes in Alzheimer's brains.
Gene networks linked to cellular signaling, gene regulation, and metabolism were associated with AD.
Genetic variants linked to AD influenced gene expression in brain tissue.

Clinical Implications

The findings underscore the importance of including diverse populations in Alzheimer's research to identify unique and shared disease mechanisms. Clinicians should consider these genetic insights when assessing risk and developing treatment plans for patients from different racial backgrounds.

Conclusion

This study enhances our understanding of Alzheimer's disease by revealing both shared and population-specific genetic factors. Continued research in diverse cohorts is crucial for advancing therapeutic strategies.